AA
DGX icon

Apriem Advisors’s Quest Diagnostics DGX Stock Holding History

Apriem Advisors’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-16
Closed -$2K – 232
2017
Q1 		$2K Sell
16
-18
-53% -$1.72K ﹤0.01% 585
2016
Q4 		$3K Buy
34
+16
+89% +$1.38K ﹤0.01% 567
2016
Q3 		$2K Hold
18
– – ﹤0.01% 539
2016
Q2 		$1K Hold
18
– – ﹤0.01% 556
2016
Q1 		$1K Buy
+18
New +$1.21K ﹤0.01% 552

Other funds holding DGX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Apriem Advisors's DGX Position: Q2 2017 in Review

Apriem Advisors sold out of Quest Diagnostics (DGX) in Q2 2017, closing a stake of 16 shares — an estimated $2K sold.

Apriem Advisors first reported a position in DGX in Q1 2016 and held it in 5 quarters. The position peaked at $3K in Q4 2016. 643 funds tracked by Wall St. Rank hold DGX as of Q2 2017.

  • Apriem Advisors reported no remaining Quest Diagnostics position as of Q2 2017 after selling out during the quarter.
  • Apriem Advisors sold 16 Quest Diagnostics shares in Q2 2017, an estimated $2K.
  • Apriem Advisors first reported a position in Quest Diagnostics in Q1 2016 and held it in 5 quarters.
  • Apriem Advisors's Quest Diagnostics position peaked at $3K in Q4 2016.
  • 643 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2017.

Based on Apriem Advisors's 13F filing for Q2 2017, filed 4 Aug 2017.